<p><b>Copyright information:</b></p><p>Taken from "Differences in Menopausal Hormone Therapy Use among Women in Germany between 1998 and 2003"</p><p>http://www.biomedcentral.com/1472-6874/7/19</p><p>BMC Women's Health 2007;7():19-19.</p><p>Published online 18 Oct 2007</p><p>PMCID:PMC2233614.</p><p></p> MHT = Menopausal hormone therapy. EPT-WHI = combined estrogen plus progestin therapy arm of the Women's Health Initiative randomized controlled trial. * p < 0.05, ** p < 0.001, compared to age specific prevalence in the 1997–1999 survey
In the last decade, the risk benefits ratio of MHT has been evaluated mainly in terms of cardiovascu...
<p><b>Copyright information:</b></p><p>Taken from "Remarkable change in age-specific breast cancer i...
Summary.: Objectives: To compare frequency and patterns of hormone replacement therapy (HRT) between...
Background: To examine the differences in menopausal hormone therapy (MHT) use and user profiles amo...
BACKGROUND: Prescribing of menopausal hormone therapy (MHT) declined drastically after publication o...
Objective: To determine regional variations in the prevalence and applied therapy regimes of current...
International audienceObjectives Menopausal hormone therapy (MHT) use is characterized by important ...
Objective: To describe the prevalence and to assess type and indicators of hormone replacement thera...
Objectives: To describe the trends in the prevalence of use menopausal hormone therapy (MHT) in Swed...
Menopausal Hormone Therapy (MHT) use in Australia fell by 55% from 2001 to 2005, following the relea...
Aim To report in a uniform way the change in MHT use in European countries. To evaluate whether the ...
BACKGROUND: In Germany, there is a lack of population-based data related to the use of gynaecologica...
Copyright © 2009 International Menopause SocietyObjective To describe the prevalence of menopausal h...
Introduction The use of menopausal hormone therapy (MHT) has decreased in many countries in the past...
The objective of this study was to describe trends in the use of hormone replacement therapy (HRT) i...
In the last decade, the risk benefits ratio of MHT has been evaluated mainly in terms of cardiovascu...
<p><b>Copyright information:</b></p><p>Taken from "Remarkable change in age-specific breast cancer i...
Summary.: Objectives: To compare frequency and patterns of hormone replacement therapy (HRT) between...
Background: To examine the differences in menopausal hormone therapy (MHT) use and user profiles amo...
BACKGROUND: Prescribing of menopausal hormone therapy (MHT) declined drastically after publication o...
Objective: To determine regional variations in the prevalence and applied therapy regimes of current...
International audienceObjectives Menopausal hormone therapy (MHT) use is characterized by important ...
Objective: To describe the prevalence and to assess type and indicators of hormone replacement thera...
Objectives: To describe the trends in the prevalence of use menopausal hormone therapy (MHT) in Swed...
Menopausal Hormone Therapy (MHT) use in Australia fell by 55% from 2001 to 2005, following the relea...
Aim To report in a uniform way the change in MHT use in European countries. To evaluate whether the ...
BACKGROUND: In Germany, there is a lack of population-based data related to the use of gynaecologica...
Copyright © 2009 International Menopause SocietyObjective To describe the prevalence of menopausal h...
Introduction The use of menopausal hormone therapy (MHT) has decreased in many countries in the past...
The objective of this study was to describe trends in the use of hormone replacement therapy (HRT) i...
In the last decade, the risk benefits ratio of MHT has been evaluated mainly in terms of cardiovascu...
<p><b>Copyright information:</b></p><p>Taken from "Remarkable change in age-specific breast cancer i...
Summary.: Objectives: To compare frequency and patterns of hormone replacement therapy (HRT) between...